Unlocking the Full Potential of Cell-based Production

Pulzar Technology is a patented platform developed by St Andrews Pharmaceutical Technology to dramatically enhance the performance of mammalian cell culture, driving higher transgene expression, improved cell health and greater productivity

What is Pulzar Technology

Pulzar Technology is based on the principles of bioelectrical conditioning, an approach widely used in human and veterinary medicine, where low-energy stimulation has been shown to influence cellular activity and support tissue function

Adapted for pharmaceutical and biological research applications, Pulzar creates a controlled electromagnetic environment designed to support cellular performance and optimise the physical interactions involved in gene delivery, expression, and productivity

CUMULATIVE PULZAR SIGNAL OVER 60 SECONDS

cumulative pulzar signal over 60 seconds graph

How it works

Pulzar combines two complementary platforms that can be used independently or together for maximum impact:

PulzFector™

Placed directly inside a standard CO₂ incubator, the PulzFector device conditions cells in situ — enhancing overall cell culture performance without altering existing workflows

pulzfector device image front

Pulzar Reagent Conditioner™

reagent device image front

Used as a standalone benchtop device, the Pulzar Reagent Conditioner optimises the formation and stability of polyplexes between transfection reagents and nucleic acids or proteins —enhancing delivery efficiency at the molecular level

Why it Matters

By addressing ​the major bottlenecks in cell based processes, Pulzar delivers a uniquely powerful advantage:

✅  Higher success rates 
✅  Greater consistency 
✅  Increased yield per experiment 
✅  Reduced time to results

Bioelectrical Conditioning, Lasting Impact